High serum levels of CSF1 correlate with poor prognosis and increased metastasis in patients with breast cancer[15], [39] Further, increased levels of CSF1 in the tumor microenvironment correlate with increased vessel density and metastasis[20], [21]. Here, CSF1 is linked to breast carcinoma.